Economic Case For FeNO In The Management Of Asthma
Economic Case For FeNO In The Management Of Asthma
As you might be aware, ARNS have been working with the AAC on a couple of projects (Severe asthma and FeNO). Recently, the Pathway Transformation Funds have been allocated but if you’ve been considering the use of FeNO, and weren’t successful, and needed the evidence behind why this is so important in the diagnosis and monitoring of asthma patients.
Download the report:
The Economic Case for Fractional Exhaled Nitric Oxide Report